Investigation of lifestyle risks exposure as response predictor of gefitinib in non-small cell lung cancer patients.
Y. Wang
No relevant relationships to disclose
H. Ying
No relevant relationships to disclose
X. S. Wang
No relevant relationships to disclose
Q. Shi
No relevant relationships to disclose
S. Chen
No relevant relationships to disclose